The American Academy of Pediatrics lit the fuse in 2023. Their recommendation to use GLP-1 weight-loss drugs in children and adolescents wasn’t just a nod to pharmaceutical innovation — it was a ...

While Rosie O’Donnell, 63, made a name for herself as a Broadway star and host of the Emmy-winning talk show The Rosie ...

For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality.

GLP-1 receptor agonists are an important drug class and have become widely popular due to their effectiveness in weight ...

A major new study has shown that a group of drugs called GLP-1 receptor agonists offer strong protection for both the kidneys ...

Another study linked GLP-1 receptor agonist use with higher odds of developing nonarteritic anterior ischemic optic ...

For patients with idiopathic intracranial hypertension, GLP-1 RA treatment is linked with improved clinical outcomes compared with conventional therapies.

Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.

GLP-1s (glucagon-like peptide-1 receptor agonists), like Wegovy, Ozempic, or generic liraglutide, have helped you reach your ...

Researchers conducted the ACHIEVE-1 trial to assess the effect of orfoglipron on glycemic control among patients with early-stage type 2 diabetes.

Harvard T.H. Chan School of Public Health suggests combining GLP-1 weight-loss medication with tailored nutrition and ...

There's been plenty of buzz about this class of drug, following publication of a high-profile trial this year. How much do we ...